Methoxisopropamine

{{short description|Chemical compound}}

{{drugbox

| drug_name = MXiPr

| image = Methoxisopropamine.svg

| image_class = skin-invert-image

| legal_CA = Schedule I

| legal_UK = Class B

| legal_DE = NpSG

| C = 16 | H = 23 | N = 1 | O = 2

| IUPAC_name = 2-(isopropylamino)-2-(3-methoxyphenyl)cyclohexan-1-one

| CAS_number = 2666932-55-2

| ChemSpiderID =

| PubChem = 163192824

| UNII = KHM3GXB3S9

| smiles = CC(C)NC1(CCCCC1=O)c1cccc(OC)c1

| StdInChI = 1S/C16H23NO2/c1-12(2)17-16(10-5-4-9-15(16)18)13-7-6-8-14(11-13)19-3/h6-8,11-12,17H,4-5,9-10H2,1-3H3

| StdInChIKey = FTQIVDGNGXPEKP-UHFFFAOYSA-N

}}

MXiPr (Methoxisopropamine, Isopropyloxetamine, Isopropyxetamine') is a recreational designer drug with dissociative effects. It is an arylcyclohexylamine derivative, related to drugs such as ketamine and methoxetamine. It was first identified in Slovenia in December 2020,{{cite web | url = https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/MXiPr-ID-2197-20_report.pdf | title = Analytical Report for MXiPr | quote = (2‐(3‐methoxyphenyl)‐2‐[(propan‐2‐yl)amino]cyclohexan‐1‐one C16H23NO2) | work = National Forensic Laboratory, Police, Ministry of the Interior | publisher = Republic of Slovenia | access-date = 2021-06-09 | archive-date = 2022-01-15 | archive-url = https://web.archive.org/web/20220115185111/https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/MXiPr-ID-2197-20_report.pdf | url-status = bot: unknown }} and was made illegal in Hungary in April 2021.{{cite web | url = https://web.archive.org/web/20210601000000*/https://ec.europa.eu/growth/tools-databases/tris/index.cfm/en/search/?trisaction=search.detail&year=2021&num=225&dLang=EN | title = Amendment of Decree No 55/2014 of 30 December 2014 on substances or groups of compounds classified as new psychoactive substances | id = 2021/225/HU | work = Minister for Human Capacities | publisher = Government of Hungary }}